Cencora Q4 FY25: where the revenue came from and where it went
The whole income statement of Cencora for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jul 1 – Sep 30, 2025
- Reported
- Nov 25, 2025
Revenue$83.73B
+6% year over year
Gross profit$2.95B
4% margin
Operating profit$0.02B
0% margin
Net profit−$0.34B
0% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 83.73 | 100% | +6% |
| US healthcare solutions | 75.79 | 91% | +6% |
| International healthcare | 7.95 | 9% | +8% |
| Cost of revenue | −80.78 | 96% | |
| Gross profit | 2.95 | 4% margin | |
| SG&A | −1.75 | 2% | +0pp |
| Other | −1.19 | 2% | +0pp |
| Operating profit | 0.02 | 0% margin | +0pp |
| Interest & other costs | −0.21 | ||
| Tax | −0.15 | ||
| Net profit | −0.34 | 0% margin | +0pp |
112 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest